eli lilly tirzepatide cease and desist letter Stop selling off-brand weight loss drugs, warns companies Drugmakers battle pharmacies over compounded

Typically, doctors follow FDA guidelines: GLP-1 agonists are approved for people with a BMI of 30 or above, or BMI of 27+ if you have conditions such as high blood pressure, high cholesterol, or type 2 diabetes [intermountainhealthcare.org]

Ozempic is contraindicated in patients with a personal or family history of MTC or in patients with MEN 2, and in patients with a hypersensitivity reaction to semaglutide or to any of the excipients in Ozempic

PMID: 33772451

Salehi M et al (2013) Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized, double-blind, placebo-controlled trial

When you and your provider discuss GLP-1 therapy optionswhether compounded semaglutide, tirzepatide, or other formulationsincorporating genetic insights alongside biomarker data (hydration status, electrolyte panels) can help create a personalized monitoring and support plan

3 using antioxidants to suppress FA cytotoxicity